Providers/Grant Support
This activity is provided by Integrity CE, LLC.
This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc and Sanofi.
Credits Available
- Physicians — maximum of 0.75 AMA PRA Category 1 Credit™
All other healthcare professionals completing this course will be issued a statement of participation.
Target Audience
This educational program is designed for pulmonologists, internal medicine clinicians, and nurse practitioners and physician assistants involved in the management of patients with chronic obstructive pulmonary disease (COPD).
Program Overview
COPD remains a leading cause of morbidity and mortality, with exacerbations driving disease progression, healthcare utilization, and diminished quality of life. Even with advances in inhaled therapies, clinicians continue to face real-world challenges, from recognizing and assessing exacerbations to integrating biomarker-guided care and applying evolving Global Initiative for Obstructive Lung Disease (GOLD) treatment pathways, including biologic options, in everyday practice.
In this interactive webcast expert faculty will discuss how to navigate key challenges, translate emerging evidence into clinical practice, and optimize care for your patients.
Learning Objectives
Upon completion of this educational activity, participants should be able to:
- Implement strategies for earlier intervention and escalation to reduce future exacerbation risk in patients with COPD
- Discuss challenges and solutions for the effective use of biomarker assessment in management of COPD
Faculty
MeiLan Han, MD, MS
Henry Sewall Endowed Professor
Chief, Pulmonary and Critical Care Medicine
University of Michigan
Ann Arbor, Michigan
Fernando J. Martinez, MD, MS
Professor of Medicine
Joseph D. Early Chair in Biomedical Research
Vice Chair, Clinical and Translational Research
Academic Chief, Division of Pulmonary, Allergy, and Critical Care Medicine
University of Massachusetts
Chan Medical School
Worcester, Massachusetts
Accreditation Statement
Integrity CE, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation
Integrity CE, LLC designates this enduring activity for a maximum of 0.75 AMA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
Disclosures of Conflicts of Interest
MeiLan Han, MD, MS
Consulting: Aerogen, Altesa Biopharma, Amgen, AstraZeneca, Bristol Myers Squibb, Boehringer Ingelheim, Chiesi, Cipla, DevPro, GSK, Merck, Mylan, Novartis, Owkin, Polarian, Pulmonx, Regeneron, Roche, Sanofi, Teva, UpToDate, Verona, Zymeworks
Data Safety Monitoring Board: Medtronic, Novartis
Research Support: AstraZeneca, Biodesix, Boehringer Ingelheim, Galvanize Therapeutics, Novartis, Nuvaira, Sanofi, Sunovion
Stock Options: Altesa, Meissa
Fernando J. Martinez, MD, MS
Advisory Boards: AstraZeneca, Chiesi, GSK, Sanofi/Regeneron
Principal Investigator Global Study: AstraZeneca, Chiesi, Sanofi/Regeneron
Steering Committee Global Study: GSK
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
A statement of credit will be issued only upon receipt of a completed posttest with a score of 40% or better and a completed activity evaluation form. Certificates will be available for the participant to download.
Course Viewing Requirements
Supported Browsers:
Desktop: Newest and last prior version of Google Chrome, Firefox, Safari, and Microsoft Edge
Mobile devices: Newest and last prior version of Safari and Google Chrome
Supported Phones & Tablets:
All devices
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Integrity CE, LLC does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition.
Contact Information
For information about ACCME accreditation of this activity, please contact Integrity CE, LLC at (855) 835-4004 or [email protected].